Vaccine Response Study for Monkeypox
Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · Other
This trial is looking for adults who are at high risk of monkeypox infection and have either HIV or not. Participants will receive a vaccine and help researchers understand how well it works and how the body responds.
You may be able to join if
- I am 18 years old or older.
- I am willing to follow the study's requirements.
- I understand the information given to me and can give my consent.
You may not be able to join if
- I have a medical condition that might increase my risks.
- I have a condition that could interfere with the study.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Sorted by distance from Idaho
Loading trial locations…